Will mandatory folic acid fortification prevent or promote cancer?

被引:234
作者
Kim, YI
机构
[1] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada
[2] Univ Toronto, Dept Nutr Sci, Toronto, ON M5S 1A8, Canada
[3] St Michaels Hosp, Div Gastroenterol, Toronto, ON M5B 1W8, Canada
关键词
folic acid fortification; folate; cancer; carcinoenesis; DNA methylation; neural tube defects;
D O I
10.1093/ajcn/80.5.1123
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
An overwhelming body of evidence for a protective effect of peri conceptional folic acid supplementation against neural tube defects (NTDs) led to mandatory folic acid fortification in the United States. The effectiveness of folic acid fortification in improving folate status has already been shown to be quite striking, with a dramatic increase in blood measurements of folate in the United States. Preliminary reports also suggest a significant reduction (approximate to15-50%) in NTDs in the United States. The Success of folic acid fortification in improving folate status and in reducing NTD rates is truly a public health triumph and provides a paradigm of collaboration between science and public health policy. Although folic acid is generally regarded as safe. there continues to be concern that folic acid fortification may have adverse effects in subpopulation groups not originally targeted for fortification. In this regard, an emerging body of evidence suggests that folic acid supplementation may enhance the development and progression of already existing, undiagnosed premalignant and malignant lesions. Over the past few years, the US population has been exposed to a significant increase in folate intake, for which essentially no data on safety exist. The potential cancer-promoting effect of folic acid supplementation needs to be considered in carefully monitoring the long-term effect of folic acid fortification on the vast majority of the US population, who are not at risk of NTDs.
引用
收藏
页码:1123 / 1128
页数:6
相关论文
共 61 条
  • [1] Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501
  • [2] [Anonymous], 1991, Lancet, V338, P131, DOI 10.1016/0140-6736(91)90133-A
  • [3] [Anonymous], 1998, DIETARY REFERENCE IN, P196
  • [4] [Anonymous], 1992, MMWR-MORBID MORTAL W, V41, P1
  • [5] EFFECTS OF FOLATE-DEFICIENCY AND SUPPLEMENTATION ON METHYLNITROSOUREA-INDUCED RAT MAMMARY-TUMORS
    BAGGOTT, JE
    VAUGHN, WH
    JULIANA, MM
    ETO, I
    KRUMDIECK, CL
    GRUBBS, CJ
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (22): : 1740 - 1744
  • [6] Folic acid supplements and fortification affect the risk for neural tube defects, vascular disease and cancer: Evolving science
    Bailey, LB
    Rampersaud, GC
    Kauwell, GPA
    [J]. JOURNAL OF NUTRITION, 2003, 133 (06) : 1961S - 1968S
  • [7] Prevention of neural-tube defects with folic acid in China
    Berry, RJ
    Li, Z
    Erickson, JD
    Li, S
    Moore, CA
    Wang, H
    Mulinare, J
    Zhao, P
    Wong, LYC
    Gindler, J
    Hong, SX
    Correa, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (20) : 1485 - 1490
  • [8] DELAYED TUMOR ONSET IN TRANSGENIC MICE FED A LOW-FOLATE DIET
    BILLS, ND
    HINRICHS, SH
    MORGAN, R
    CLIFFORD, AJ
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (05): : 332 - 337
  • [9] Neural-tube defects
    Botto, LD
    Moore, CA
    Khoury, MJ
    Erickson, JD
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (20) : 1509 - 1519
  • [10] Trends in neural tube defects in Western Australia
    Bower, C
    Ryan, A
    Rudy, E
    Miller, M
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH, 2002, 26 (02) : 150 - 151